233 related articles for article (PubMed ID: 26604797)
1. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection.
Sha N; Xie L; Chen T; Xing C; Liu X; Zhang Y; Shen Z; Xu H; Wu Z; Hu H; Wu C
Onco Targets Ther; 2015; 8():3401-6. PubMed ID: 26604797
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
Ukai R; Hashimoto K; Nakayama H; Iwamoto T
Jpn J Clin Oncol; 2017 May; 47(5):447-452. PubMed ID: 28184446
[TBL] [Abstract][Full Text] [Related]
3. Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer.
Li G; Song H; Wang J; Bao Y; Niu Y
Sci Rep; 2016 Jun; 6():27586. PubMed ID: 27279531
[TBL] [Abstract][Full Text] [Related]
4. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
6. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
7. Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder.
Xu H; Xie L; Liu X; Zhang Y; Shen Z; Chen T; Qiu X; Sha N; Xing C; Wu Z; Hu H; Wu C
Oncol Lett; 2017 Sep; 14(3):3522-3528. PubMed ID: 28927108
[TBL] [Abstract][Full Text] [Related]
8. Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection.
Luo Q; Liu Y; Zhao H; Guo P; Wang Q; Li W; Li G; Wu B
World J Urol; 2020 Nov; 38(11):2849-2856. PubMed ID: 31965287
[TBL] [Abstract][Full Text] [Related]
9. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V
World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation].
Wang C; Sun ZQ; Liu MY; Zhang JJ; Liu G; Feng Y; Yan YF; Cui HW; Li G
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):691-695. PubMed ID: 34289563
[No Abstract] [Full Text] [Related]
11. Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
von Rundstedt FC; Mata DA; Groshen S; Stein JP; Skinner DG; Stadler WM; Cote RJ; Kryvenko ON; Godoy G; Lerner SP
BJU Int; 2015 Jul; 116(1):44-9. PubMed ID: 25413313
[TBL] [Abstract][Full Text] [Related]
12. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study.
Zhang Y; Xie L; Chen T; Xie W; Wu Z; Xu H; Xing C; Sha N; Shen Z; Qie Y; Liu X; Hu H; Wu C
Onco Targets Ther; 2016; 9():605-11. PubMed ID: 26869805
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer.
Branchereau J; Larue S; Vayleux B; Karam G; Bouchot O; Rigaud J
Clin Genitourin Cancer; 2013 Jun; 11(2):182-8. PubMed ID: 23276589
[TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
15. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.
Zhao G; Wang C; Tang Y; Liu X; Liu Z; Li G; Mei Y
Sci Rep; 2019 Mar; 9(1):5323. PubMed ID: 30926888
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin.
Fukumoto K; Kikuchi E; Mikami S; Miyajima A; Oya M
BMC Urol; 2016 Jan; 16():5. PubMed ID: 26785916
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Clinical Predictors of Lymphovascular Invasion of Bladder Tumors at Transurethral Resection Pathology.
Yoneda K; Utsumi T; Wakai K; Oka R; Endo T; Yano M; Kamiya N; Hiruta N; Suzuki H
Curr Urol; 2020 Oct; 14(3):135-141. PubMed ID: 33224006
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
20. Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis.
Kim HS; Kim M; Jeong CW; Kwak C; Kim HH; Ku JH
Urol Oncol; 2014 Nov; 32(8):1191-9. PubMed ID: 24954108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
